WHO / INTERNATIONAL PROCUREMENT
WHO Prequalification
CURRENT · WORLD HEALTH ORGANIZATION
WHO Prequalification of Pharmaceutical Products
TRS 1067 Annex 4, published 9 June 2026, describes assessment of eligible pharmaceutical products against WHO requirements.
Assessment may cover dossiers, API information, manufacturing-site and relevant clinical/CRO inspections, quality-control testing and WHO GMP. Listing is not national market authorization or WHO endorsement.
- Product eligibility
- Applicable assessment pathway
- Dossier / API evidence
- GMP and relevant inspections
- WHO assessment
NEXT STEP
Need professional support?
Independent professional support pathways. Pharma Gate does not assess eligibility, certify suppliers or submit applications to WHO.
WORLD → EGYPT
Entering the Egyptian market?
International manufacturer · Product · Egypt · Regulatory authority · Applicable intelligence · Market entry · Professional support
Explore Egypt regulatory intelligenceNational market authorization remains separate from WHO prequalification.
Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.
How we verify intelligence
Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.
Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.